Minimum effective intensity of oral anticoagulant therapy in primary prevention of coronary heart disease

Archives of Internal Medicine

Volumn 160, Issue 16, 2000, Pages 2462-2468

  MacCallum, P K ^a   Brennan, P J ^a   Meade, T W ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 7; FIBRINOGEN; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FOLLOW UP; HUMAN; INTERNATIONAL STANDARD UNIT; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; THROMBOSIS;

EID: 0034638065     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.16.2462     Document Type: Article

References (22)

1. Oral anticoagulants: Mechanism of action, clinical effectiveness, and optimal therapeutic range
2. A method to determine the optimal intensity of oral anticoagulant therapy
3. The Scylla and Charybdis of oral anticoagulant treatment
4. Thrombosis prevention trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
5. Haemostatic function and cardiovascular death: Early results of a prospective study
6. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
7. Optimal anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia
8. Optimal oral anticoagulant therapy in patients with mechanical heart valves
9. Hemostatic factors and inflammatory disease
10. Cellular adhesion molecules and atherogenesis
11. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein
12. Atherosclerosis - An inflammatory disease
13. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial
14. Thrombotic events during oral anticoagulant treatment: Results of the inception-cohort, prospective, collaborative ISCOAT study
15. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
16. Double-blind randomised trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer
17. Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users: Primary end points, analysis from the ATACS trial
18. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement
19. Randomised double-blind trial of fixed low-dose warfarin with aspirin after myocardial infarction
20. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts
21. Long-term oral anticoagulant therapy in patients with unstable angina or suspected non-Q-wave myocardial infarction: Organization to assess strategies for ischemic syndromes (OASIS) pilot study results